renal cell carcinoma

  • March 5, 2024  
  • March 5, 2024  

    How Would a Harvard Oncologist Manage His Own Metastatic Kidney Cancer?

    With: David J. Einstein, MD

    When facing a frightening new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks kidney cancer expert David J. Einstein, MD, how he would handle his own hypothetical case of kidney cancer. Dr. Einstein is Assistant Professor of Medicine in the Genitourinary Oncology Program at Harvard Medical School’s Beth Israel Deaconess Medical Center.… Read more »

  • August 5, 2022  

    Summary of Kidney Cancer Highlights from ASCO GU 2022 Bookmark

    George Lundberg, MD

    This article from the International Kidney Cancer Coalition (IKCC) outlines updates on treatment options for renal cell carcinoma as presented at the 2022 American Society of Clinical Oncology Genitourinary (ASCO GU) Symposium.

    .

  • August 5, 2022  

    Good for Bladder Cancer, Better for Kidney Cancer Bookmark

    George Lundberg, MD

    This article from the National Cancer Institute’s Center for Cancer Research outlines new clinical trial results showing that combining the drugs cabozantinib and nivolumab doubled progression-free survival for people with advanced renal cell carcinoma compared to giving cabozantinib alone.

    .

  • February 19, 2021  

    Renal Cell Carcinoma—An Overview Bookmark

    George Lundberg, MD

    Curated by Editor in Chief George Lundberg, MD, who notes:

    There are now many precision oncology treatments for the most common type of kidney cancer, renal cell carcinoma, which represents about 3% of all potentially lethal cancers in America. This summary from Medscape details all the traditional treatment approaches, as well as newer considerations.

    .

  • December 23, 2019  

    Renal Cell Cancer Treatment: The Old, the Almost Old, and the New

    Emma Shtivelman, PhD

    Clear cell renal cell cancer (ccRCC) is the predominant type of kidney cancer, accounting for 70% to 75% of all kidney cancers. Here, I outline the current treatment landscape for ccRCC, highlighting what’s new and what’s on the horizon. Surgical removal of the cancerous kidney is most often the first treatment after diagnosis, especially if the tumors exceed 3- to 4 cm in size.… Read more »

  • December 13, 2019  

    New Standard of Care for Metastatic Renal Cell Carcinoma Bookmark

    George Lundberg, MD

    Article from Medscape curated by Editor in Chief George Lundberg, MD, who notes: 

    This piece describes huge improvements in the standard of care and outcomes from combo therapy in metastatic renal cell carcinoma.

    Go to full article published by Medscape.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  • November 12, 2019  

    Microwave Ablation Feasible for cT1b Renal Cell Carcinoma Bookmark

    George Lundberg, MD

    Article from Renal and Urology News curated by Editor in Chief George Lundberg, MD, who notes: 

    Microwave ablation has been shown to be a viable alternative to both radical and partial nephrectomy for kidney cancers that measure less than 7 cm in diameter. Outcomes for the two approaches are comparable.

    Go to full article published by Renal and Urology News.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.